2004
DOI: 10.1016/j.toxlet.2004.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Carcinogenicity categorization of chemicals—new aspects to be considered in a European perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
97
0
3

Year Published

2005
2005
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 177 publications
(100 citation statements)
references
References 74 publications
0
97
0
3
Order By: Relevance
“…To provide greater emphasis to the Expert Panel's WoE conclusion, Table 4 provides a comparison between a set of characteristics found in confirmed genotoxic carcinogens (Bolt et al 2004;Petkov et al 2015) and the genotoxic activity profiles for glyphosate, AMPA, and GBFs. There is virtually no concordance between the two sets of characteristics.…”
Section: Genotoxicity Classification and Moamentioning
confidence: 99%
“…To provide greater emphasis to the Expert Panel's WoE conclusion, Table 4 provides a comparison between a set of characteristics found in confirmed genotoxic carcinogens (Bolt et al 2004;Petkov et al 2015) and the genotoxic activity profiles for glyphosate, AMPA, and GBFs. There is virtually no concordance between the two sets of characteristics.…”
Section: Genotoxicity Classification and Moamentioning
confidence: 99%
“…Some of these known impurities are potential mutagens or carcinogens and genotoxic impurities are those have potential to cause cancer in humans. 2,3 Keeping in view of its consequence, European Medicines Agency and ICH [ICH M7] have framed guidelines genotoxic impurities in the drug substance. 4,5 These guidelines proposed a threshold limit of toxicological concern value (1.5 µg/day) of genotoxic impurities in the drug substance.…”
Section: Introductionmentioning
confidence: 99%
“…Pharmaceutical genotoxic impurities (PGIs) may induce genetic mutations, chromosomal breaks (rearrangements) and they have potential to cause cancer in human [3][4]. Therefore exposure to even low levels of such impurities present in final active pharmaceutical ingredient (API) may be of significant toxicol importance [5].…”
Section: Introductionmentioning
confidence: 99%